Abstract:BACKGROUND: Primary dystonia is a heterogeneous disease, with a complex genetic basis. In previous studies, primary dystonia was classified according to age of onset involved regions, and other clinical characteristics. With the development of molecular genetics, new virulence genes and sites have been discovered. Therefore, there is a gradual understanding of the various forms of dystonia, based on new viewpoints. There are 15 subtypes of dystonia based on the molecular level, i.e., DYT1 to DYT15.OBJECTIVE: To analyze the genetic development of dystonia in detail, and to further investigate molecular mechanisms of dystonia.RETRIEVAL STRATEGY: A computer-based online search was conducted in PubMed for English language publications containing the keywords "dystonia and genetic" from January 1980 to March 2007. There was 105 articles in total. Inclusion criteria: (1) the contents of the articles should closely address genetic classification and molecular mechanisms of primary dystonia: (2) the articles published in recent years or in high-impact journals took preference. Exclusion criteria: duplicated articles.LITERATURE EVALUATION: The selected articles were on genetic classification and molecular genetics mechanism of primary dystonia. Of those 27 were basic or clinical studies.DATA SYNTHESIS: (1) Dystonia is a heterogeneous disease with a complex genetic basis. According to the classification of the Human Genome Organization, there 15 dystonia subtypes, based on genetics, i.e.. DYT1-DYT15, including primary dystonia, dystonia plus syndrome degeneration plus dystonia and paroxysmal dyskinesia plus dystonia. (2) To date, the chromosomes of 13 subtypes have been localized: however, DYT2 and DYT4 remain unclear. Six subtypes have been located within virulence genes. Specifically, torsinA gene expression results in the DYT1 genotype: autosomal dominant GTP cyclohydrolase 1 gene expression and recessive tyrosine hydroxylase expression result in the DYT5 genotype respectively; the epsilon-sarcoglycan gene is involved in DYT11: Na(+)/K(+)-ATP enzyme a 3 chain gene in DYT12; TATA-conjugated protein-associated factor 1 gene in DYT3; and myofibril regulatory factor gene in DYT8. (3) Different types of dystonia exhibit various clinical characteristics and specific clinical manifestations. (4) Many elements regarding the molecular mechanism of dystonia have been determined. However, many components remain poorly understood. For example detailed pathogenesis remains unclear. Various forms of dystonia exhibit similar problems. Moreover, a single form of dystonia may be a result of two or more different chromosomal mutations. In addition, more studies are needed to fully understand chromosome apposition and virulence genes involved in dystonia.CONCLUSION: The discovery of virulence genes and localizations of newly classified forms of dystonia are beneficial to further understanding the molecular mechanisms of dystonia.

Deciphering the Pathophysiological Mechanisms Underpinning Myoclonus Dystonia Using Pluripotent Stem Cell-Derived Cellular Models

Patient-specific Induced Pluripotent Stem Cell Models in Mitochondrial Diseases.

The Progress in the Study of the Pathogenesis of Primary Dystonia

Induced Pluripotent Stem Cells: Ex Vivo Models for Human Diseases Due to Mitochondrial DNA Mutations

Mitochondrial Disease-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization.

Generation of neural cells from DM1 induced pluripotent stem cells as cellular model for the study of central nervous system neuropathogenesis.

Dystonia genes and their biological pathways

Transcriptomic disruption and functional hypoactivity in DYT-SGCE MGE-patterned inhibitory neurons

Striatal cell-type-specific molecular signatures reveal therapeutic targets in a model of dystonia

Emerging Molecular‐Genetic Families in Dystonia: Endosome‐Autophagosome‐Lysosome and Integrated Stress Response Pathways

Microstructure of the cerebellum and its afferent pathways underpins dystonia in myoclonus dystonia

Recent Advances in the Genetics of Dystonia

Research Progress and Diagnostic Strategy of Genetic Pathogenesis of Dystonia

Gene-environment interaction elicits dystonia-like features and impaired translational regulation in a DYT-TOR1A mouse model

Neuromuscular Development and Disease: Learning From in vitro and in vivo Models

Scalable, optically-responsive human neuromuscular junction model reveals convergent mechanisms of synaptic dysfunction in familial ALS

Stem Cell Models and Gene Targeting for Human Motor Neuron Diseases

Genetic Classification and Molecular Mechanisms of Primary Dystonia

Perspectives on hiPSC-Derived Muscle Cells as Drug Discovery Models for Muscular Dystrophies

Is There a Role for Human Pluripotent Stem Cells in Modelling Interstitial Cells of Cajal and Gut Motility Disorders?

Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing